Contrast-enhanced US
|
|
- Maximilian Miles
- 1 years ago
- Views:
Transcription
1 대한간암연구학회제 14 차총회심포지엄 Session II: Challenges in Diagnostic Imaging Contrast-enhanced US Jae Young Lee, MD Seoul National University Hospital
2 Outline Introduction Main part 1. US contrast 2. Dx of HCC on CEUS 3. HCC histologic grade on CEUS 4. Cost-Efficiency of CEUS 5. Perfusion Study of CEUS Summary
3 : CEUS, CT, MR HAP: Hypervascularity EP : Wash-out Introduction
4 : CT, MR, Angio HAP: Hypervascularity EP : Wash-out Introduction
5 Outline Introduction Main part 1. US contrast 2. Dx of HCC on CEUS 3. HCC histologic grade on CEUS 4. Cost-Efficiency of CEUS 5. Perfusion Study of CEUS Summary
6 1. US Contrast Agents SonoVue (Bracco, Milan, Italy) : available in Korea Gas: SF6 (sulfur hexafluoride) 2.5 μm Phospholipid shell Maximum backscattering: about 3 MHz Elimination half-life: 6 min 80%: via the lungs in 11 min Continuous scanning after injection Vascular phase up to 5 min after injection
7 US Contrast Agents Sonazoid (Daiichi Sankyo, Tokyo, Japan) 2.6 μm Gas: Perfluorobutane Lipid (not disclosed) Injection Vascular phase Post vascular phase 10 min 1 hr Vascular phase ( up to 5 min) Post-vascular phase (10 min to 1 hr) : Kupffer cell uptake Possible combination of arterial phase and post-vascular phase Defect Reperfusion imaging
8 Conclusive Dx Rate : 80% Kudo M, Hatanaka K, Inoue T, Maekawa K. Oncology 2010;78 Suppl 1:60-7.
9
10
11 2. Dx of HCC on CEUS Ability to detect arterial hypervascularity in in HCCs in cirrhosis Author No. Lesions Lesion size (cm) Detection rate CEUS (%) CT/MRI (%) Gaiani ± CT 100 Bolondi CT CT 87 Forner MRI 85 Maruyama ± non-hypervascular HCC on CT Mandai ± CT 82 Giorgio (0.9-2) ( )
12 F/66 S/P RFA due to HCCs
13
14
15
16
17 M/53 Liver cirrhosis
18 Arterial phase 3-2 Portal V phase Delayed phase
19 Early arterial phase 3-3
20 Portal Venous Phase 3-4
21 Enhancement pattern summary 3-5 Arterial phase
22 3-6 Precontrast AP PVP HB phase HASTE T2WI
23 Dx of HCC on CEUS Excellent for depiction of arterial hypervascularity Giorgio 2007 HCCs < or = 10 mm : MR > CEUS HCCs > 10 mm : CEUS > MR Useful in the cases with suspicious hypervascularity on CT/MR Hepatic lesions in pts with renal dysfunction No hazard for liver and kidneys Sono-guided targeting Hyper/Hypo vascular nodules
24 3. HCC histologic grade on CEUS Proportion of hypervascular tumors W/D: 66% M/D and P/D : 80% Proportion of hypoechoic tumor on post-vascular phase W/D: 54% M/D and P/D: 92% Arita J, Hasegawa K, Takahashi M, et al. AJR Am J Roentgenol 2011;196(6):
25 Arterial enhancement vs. Pathologic Differentiation 4 (17%) 5 (22%) 3 (4%) 3 (25%) 14 (61%) 74 (96%) 9 (75%) Jang HJ. Radiology 2007;244:898
26 Washout Time vs. Pathologic Differentiation CEUS Jang HJ. Radiology 2007;244:898
27 10s 180s Jang HJ. Radiology 2007;244:898
28 4. Cost-efficiency of CEUS Prospective studies for all hepatic nodules not characterized by US or CT France 2009 Germany 2010 Romania 2011 Korea? No. Lesio ns Performan ce 733 Sen > 80% Spf > 90% Cost Efficiency CEUS > CT or MR Concorda nce rate 84.5 % with CT/MR % with MR 316 Conclusvie Dx rate 79.1 % CEUS > CT or MR Note CT (191 Euro) MR (322 Euro) US (155 Euro) Hemangiomas (50%) FNH (18%) CT price 1.6 x CEUS CT price? x CEUS MR price 3.6 x CEUS MR price? x CEUS
29 5. Perfusion study with CEUS Advantage of CEUS Real time observation of pure vascular perfusion Easily repeatable No hazard to patients Disadvantage of CEUS Anatomical limit Motion limit Time/effort are needed for correction Perfusion studies with antiangiogenic drug Change of tumor vascularization within 1-2 wks Significantly correlated with PFS and OS Lassau N, Eur Radiol 2007;17 Suppl 6:F89-98.
30 Perfusion study with CEUS A Mouse Hepatoma Model Mice bearing H22 hepatoma Cisplatin vs placebo CEUS on day 8 Cisplatin group : significant decrease in perfusion index and maximum intensity Zhou JH, AJR Am J Roentgenol 2011;196(1):W13-7.
31 Summary 1. US contrast SonoVue : Vascular phase, > 80% thru lung Sonazoid : Post-vascular phase (Kupffer cell uptake) : Defect reperfusion imaging 2. Dx of HCC on CEUS Hypervascularity on AP : CEUS > CT CEUS > MR (> 1cm nodule) 3. HCC histologic grade on CEUS Possible prediction of HCC differentiation 4. Cost-Efficiency of CEUS Cost efficient in some countries but? in Korea 5. Perfusion Study of CEUS Promising and of clinical impact due to advantages of CEUS
32 Thank You for you attention
Contrast-Enhanced Ultrasound (CEUS)
Contrast-Enhanced Ultrasound (CEUS) Odd Helge Gilja, MD, PhD Professor Department of Medicine Haukeland University Hospital Bergen, Norway The Micro-Bubble Contrast Agents - World View IEEE Transactions
Focal Liver Lesions: Characterization with MDCT. Jorge A. Soto, M.D.
Focal Liver Lesions: Characterization with MDCT Jorge A. Soto, M.D. CT: Principle Ability to detect a liver lesion depends upon: Relationship between size and section thickness Background organ attenuation:
Detection and characterisation of focal liver lesions using contrast-enhanced ultrasonography
Detection and characterisation of focal liver lesions using contrast-enhanced ultrasonography Edward Leen Hammersmith Hospital, Imperial College, London, UK Introduction The liver is a unique organ in
Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging?
Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University CONFLICTS: US principal
What's the Best Approach to Evaluate the Liver Mass?
WHAT IS THE BEST WAY TO EVALUATE THE LIVER MASS? Mitchell L Shiffman, MD Chief, Hepatology Section Virginia Commonwealth University Medical Center Richmond, VA LIVER MASSES DISCOVERY AND SIGNIFICANCE Incidental
The Diagnosis of Liver Tumours with Ultrasound Contrast
S2-1 The Diagnosis of Liver Tumours with Ultrasound Contrast David Cosgrove Imperial College, Hammersmith Hospital, London A panel of experts recently completed updating the European Guidelines for the
Clinical Analysis of Focal Nodular Hyperplasia of the Liver in 11 Patients
Clinical Analysis of Focal Nodular Hyperplasia of the Liver in 11 Patients Purpose: The purpose of this study was to determine the clinical features of focal nodular hyperplasia (FNH) and investigate its
CONTRAST-ENHANCED ULTRASOUND OF THE LIVER:
CONTRAST-ENHANCED ULTRASOUND OF THE LIVER: ELECTRONIC ATLAS OF NORMAL ANATOMY, COMMON & UNCOMMON PATHOLOGY, & GUIDANCE FOR PROCEDURES Mollie Rashid, MD Corinne Deurdulian, MD Suzanne L. Palmer, MD DISCLOSURES
Management of Liver Cancer: In the Era of Liver Transplantation
Management of Liver Cancer: In the Era of Liver Transplantation Marwan S. Abouljoud, M.D., F.A.C.S. Benson Ford Chair Transplant and Hepatobiliary Surgery Director, Henry Ford Transplant Institute I have
Diffusion MRI of the Abdomen
Diffusion MRI of the Abdomen Robert R. Edelman, M.D. Dept. of Radiology NorthShore University Health System Feinberg School of Medicine, Northwestern University Diffusion Imaging Random motion of molecules
Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors
Gut and Liver, Vol. 10, No. 2, March 2016, pp. 283-287 ORiginal Article Evaluation of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns and Influencing Factors Wen-Tao Kong, Zheng-Biao
The most relevant new technlogies ULTRASOUND
The most relevant new technlogies ULTRASOUND 1. Contrast Enhanced Ultrasound Basics Clinical Applications 2. Elastography Mechanical Elastography Transient Dynamic E. 3. Ultrasound Simulation Teaching
Liver Imaging. Liver Imaging/Cirrhosis. Signs of Liver Failure and Portal Hypertension. Methods of Imaging the Liver. CT Workhorse of Imaging
Liver Imaging Patricia Lipford Abbitt,, MD Professor and Chief - Body Imaging Section Department of Radiology College of Medicine University of Florida Liver Imaging/Cirrhosis Number of patients with hepatitis
Modern Liver Imaging Techniques A New Era in Liver Ultrasound
Modern Liver Imaging Techniques A New Era in Liver Ultrasound Dr. Yuko Kono, M.D., Ph.D Associate Clinical Professor Departments of Medicine & Radiology University of California, San Diego, U.S.A. Modern
PET Scans in the Head and Neck. Diagnostic imaging
PET Scans in the Head and Neck Joseph C. Sniezek, MD FACS Head and Neck Surgery Tripler Army Medical Center Diagnostic imaging 1. Anatomic information -x-ray -CT -MRI -Ultrasound 2. Physiologic/Metabolic
How to Miss a Renal Mass: Guide to Pitfalls and Solutions. MDCT of the Kidneys: Decisions, Decisions, Decisions. Pitfalls in Renal Imaging
How to Miss a Renal Mass: Guide to Pitfalls and Solutions Elliot K. Fishman M.D. Johns Hopkins Hospital The most common reason for a missed diagnosis in radiology is a perceptual error, or an error in
Imaging Hepatocellular Carcinoma:
Imaging Hepatocellular Carcinoma: The Role of Radiology in Diagnosis & Treatment Rachel Jimenez Gillian Lieberman, MD March 2008 Clinical Presentation 50 year old man with chronic Hepatitis C & cirrhosis,
Hepatocellular Carcinoma: A Guide to Screening and Diagnosis
February 2012 Hepatocellular Carcinoma: A Guide to Screening and Diagnosis Reid Merryman, Harvard Medical School Year III Agenda Hepatocellular carcinoma (HCC) introduction Index patient: clinical presentation
Surveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
Moving Beyond RECIST
Moving Beyond RECIST Ihab R. Kamel, M.D., Ph.D. ikamel@jhmi.edu Associate Professor Clinical Director, MRI Department of Radiology The Johns Hopkins University School of Medicine Outline Standard measures
MRI of benign and focal liver lesions. Dr Nick Woodward Royal Free London
MRI of benign and focal liver lesions Dr Nick Woodward Royal Free London Introduction Focal liver lesions Benign Characterisation of lesions seen on other modalities Characterisation of benign hepatocellular
34 YOM potential living liver donor. 38 YO male living liver donor candidate. Adenomatosis. FNH vs Adenoma
34 YOM potential living liver donor 38 YO male living liver donor candidate Adenomatosis FNH vs Adenoma FNH Hepatobiliary agents have a role in distinguishing the two! Adenoma But beware 3 minute post
Middle-aged Woman With a Focal Liver Lesion on Imaging. Objectives
Middle-aged Woman With a Focal Liver Lesion on Imaging Bilal Hameed, MD University of California, San Francisco Objectives Common liver lesions seen in women on imaging Describe key findings on imaging
Case Report: Whole-body Oncologic Imaging with syngo TimCT
Case Report: Whole-body Oncologic Imaging with syngo TimCT Eric Hatfield, M.D. 1 ; Agus Priatna, Ph.D. 2 ; John Kotyk, Ph.D. 1 ; Benjamin Tan, M.D. 1 ; Alto Stemmer 3 ; Stephan Kannengiesser, Ph.D. 3 ;
HCC: Risk factors, surveillance and the importance of a multidisciplinary team
HCC: Risk factors, surveillance and the importance of a multidisciplinary team Anjana Pillai MD Assistant Professor of Medicine Director, Emory University Hospital Liver Tumor Clinic Division of Digestive
Radiology Caveats and Pearls in Liver Tumors
Radiology Caveats and Pearls in Liver Tumors Greg de Prisco, M.D. Staff Radiologist Baylor University Medical Center gregdeprisco@gmail.com Liver anatomy 101 Fundamentals of CT & MRI Focal Liver Lesions
FieldStrength. Asan Medical Center proves the power of pediatric whole body MRI
FieldStrength Publication for the Philips MRI Community Issue 38 Summer 2009 Asan Medical Center proves the power of pediatric whole body MRI New approaches for pediatric whole body MRI help visualize
MRI of the Liver. Pulse Sequences. Pulse Sequences. Pulse Sequences. Imaging Options. Pulse Sequences
Pulse Sequences MRI of the Liver Wm. Faulkner, B.S.,R.T.(R)(MR)(CT), FSMRT T2-W: Fast (Turbo) Spin Echo T1-W: Spoiled Gradient Echo Diffusion-Weighting Balanced Gradient Echo Pulse Sequences T2-W: Fast
Auto Registration on EPIQ Evolution 1.0
Ultrasound Automatic registration brings new levels of simplicity to image fusion advancing patient care Auto Registration on EPIQ Evolution 1.0 Fusion combines the strengths of multiple modalities Ultrasound
Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
Bile Duct Imaging: New Agents, New Sequences
Bile Duct Imaging: New Agents, New Sequences SCBT/MR March 2010 Scott B. Reeder, MD, PhD Department of Radiology University of Wisconsin Madison, WI Disclosure Advisory boards of Bayer, GE Healthcare UW
Benign Liver Tumors. Cameron Schlegel PGY-1 3/6/2013
Benign Liver Tumors Cameron Schlegel PGY-1 3/6/2013 Outline Benign Liver Tumors are, in general. Asymptomatic Diagnosed: imaging Treatment: Do no harm Unless Malignant potential Causing symptoms Differential
Neuroendocrine Tumors: A Review of CT and MRI Findings Pareen Mehta, MD and Patrick M. Colletti, MD
Neuroendocrine Tumors: A Review of CT and MRI Findings Pareen Mehta, MD and Patrick M. Colletti, MD Neuroendocrine tumors, including pancreatic neuroendocrine tumors and carcinoid tumors, are rare neoplasms
Come valutare la risposta o la progressione nei pazienti in trattamento con terapie biologiche
Come valutare la risposta o la progressione nei pazienti in trattamento con terapie biologiche Andrea Busolo U.O. di Radiologia Rocco De Vivo U.O. di Oncologia Medica ULSS 6 - Vicenza Activity and efficacy
Liver Cancer and Clinical Trials
Liver Cancer and Clinical Trials Abby Siegel MD, MS Medical Director, Hepatobiliary Oncology Columbia University Medical Center Tony Wang MD Assistant Professor, Radiation Oncology, Columbia University
Original Article The efficacy assessment of radiofrequency ablation treatment on primary hepatocellular carcinoma by contrast enhanced ultrasonography
Int J Clin Exp Med 2016;9(8):16218-16223 www.ijcem.com /ISSN:1940-5901/IJCEM0024106 Original Article The efficacy assessment of radiofrequency ablation treatment on primary hepatocellular carcinoma by
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL HEPATOCELLULAR CARCINOMA GI Site Group Hepatocellular Carcinoma Authors: Dr. Jennifer Knox, Dr. Mairead McNamara 1. INTRODUCTION
THE SECOND VERSION of Evidence-based Clinical
bs_bs_banner doi: 10.1111/hepr.12464 Special Report Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines) Norihiro
Liver Imaging: A Guide for Medical SpRs
Liver Imaging: A Guide for Medical SpRs D.E. Malone St. Vincent s University Hospital, Dublin, Ireland Core Curriculum in Hepatology SVUH 2013 Acknowledgements Ronan Ryan Sinead McEvoy Lisa Lavelle Anne
Work up of the focal liver lesion
Work up of the focal liver lesion Milan Kinkhabwala, MD Professor of Surgery Chief, Division of Transplantation Montefiore Einstein Center for Transplantation 2 Incidental findings are common with increasing
Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations. Chapter. Grade. CQ No. 1 Interferon Therapy
Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations Chapter Chapter 1 Prevention Sectio n CQ No. 1 Interferon Therapy Clinical Question 1 Does interferon
HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION. Francis Yao, M.D.
UCSF TRANSPLANT CONFERENCE - 9/28/2012 HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION Francis Yao, M.D. Professor of Clinical Medicine and Surgery Medical Director, Liver Transplantation
Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans
Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans F. Edward Boas, Aya Kamaya, Bao Do, Terry S. Desser, Christopher
HCC in HIV who and how to screen. Raffaele Bruno,MD
HCC in HIV who and how to screen Raffaele Bruno,MD Dipartimento di Scienze Cliniche Chirurgiche Diagnostiche e Pediatriche Università degli Studi di Pavia U.O. Malattie Infettive e Tropicali Fondazione
Contrast-enhanced ultrasonography (CEUS) in canine liver examination
Polish Journal of Veterinary Sciences Vol. 3, No. 4 (200), 767-773 DOI 0.2478/v08-00-0007-2 Review Contrast-enhanced ultrasonography (CEUS) in canine liver examination M. Wdowiak, A. Rychlik, R. Nieradka,
Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
2235-1795/15/0042-0085$39.50/0 85 Editorial Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe Prof. M. Kudo Editor Liver Cancer Introduction Hepatocellular
Consensus on Hepatobiliary Imaging Practice Guidelines
Consensus on Hepatobiliary Imaging Practice Guidelines 1 Practice Guidelines on Hepatobiliary Imaging: A Malaysian Perspective College of Radiology, Consensus Document Eecutive Summary i This is a consensus
Hepatocellular Carcinoma: What the hepatologist wants to know
Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have
Management of Abdominal Incidentalomas Found on Cross-sectional Imaging: Management Strategies
Management of Abdominal Incidentalomas Found on Cross-sectional Imaging: Management Strategies Michael Nipper, M.D. Q1: What Percentage of the Time Does My Radiology Group Give Specific Follow-up Recommendations
PET/CT-MRI First clinical experience
20 th April 2013, Barcelona, Sp PET/CT-MRI First clinical experience Philippe Appenzeller, MD Staff Radiologist and Nuclear Medicine Physician Department Medical Imaging, University Hospital Zurich PET/CT-MR
A Resident s Guide to the MRI diagnosis of Hepatocellular Carcinoma
Confidently See the HCC: A Resident s Guide to the MRI diagnosis of Hepatocellular Carcinoma S. Channual 1, MD; M. Patel 12, MD; A. Pahwa 2, MD, S. Bahrami, MD 1 ; S. Raman, MD 1. 1 UCLA Medical Center,
Aims and objectives. Methods and materials
Detection of early local recurrence of head and neck squamous cell carcinoma with diffusion weighted MRI and FDG PET/CT after radiotherapy: correlation between ADC and SUV values. Poster No.: C-1278 Congress:
Uitgangsvraag 2 a: Wat is de optimale beeldvorming voor diagnosestelling HCC?
Uitgangsvraag 2 a: Wat is de optimale beeldvorming voor diagnosestelling HCC? primary Studies I Study ID II Method III Patient characteristics IV Intervention(s) V Results primary outcome Bernatik 2010[1],
Medical Review Approaches to Liver Tumors
Medical Review Approaches to Liver Tumors Fuminori Moriyasu Department of Gastroenterology and Hepatology Tokyo Medical University Fuminori Moriyasu Department of Gastroenterology and Hepatology, Tokyo
Common CT Findings Secondary to Liver Tumors
Common CT Findings Secondary to Liver Tumors Lawrence Pan, MS IV New Jersey Medical School Radiology Beth Israel Deaconess Medical Center September 2006 Liver Tumors PRIMARY SECONDARY Some quick facts
Abdominal CT Perfusion: Effects of Breath Control Technique
Abdominal CT Perfusion: Effects of Breath Control Technique Poster No.: C-0068 Congress: ECR 2014 Type: Scientific Exhibit Authors: T. Yoshikawa, T. Kanda, Y. Ohno, Y. Fujisawa, N. Negi, M. 1 1 2 1 1 1
PET. Can we afford PET-CT. Positron annihilation. PET-CT scanner. PET detection
PET-CT Can we afford PET-CT John Buscombe New technology Combines functional information-pet anatomical information-ct Machine able to perform both studies in single imaging episode PET imaging depends
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant
12th & 13th May 2016 Weston Education Centre, Kings College Hospital London
EUROSON SCHOOL CEUS Course How to Incorporate CEUS into your Imaging Practice 12th & 13th Weston Education Centre, Kings College Hospital London Course fees: Standard fee - 400 Trainees & Sonographers
Management of GGO and Other Lesions Found on Screening CT Scan
Management of GGO and Other Lesions Found on Screening CT Scan AATS/STS General Thoracic Surgery Symposium American Association for Thoracic Surgery San Francisco, CA April 2012 David R. Jones MD George
Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls
Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls Mark Notley, MD; Jinxing Yu, MD; Ann S. Fulcher, MD; Mary A. Turner, MD; Don Nguyen, MD Virginia Commonwealth
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD With the widespread use of cross-sectional imaging, many renal masses are incidentally found. These need to be accurately
New Data Supporting Modified RECIST (mrecist) for Hepatocellular Carcinoma. Running Title: Modified RECIST (mrecist) for Hepatocellular Carcinoma
New Data Supporting Modified RECIST (mrecist) for Hepatocellular Carcinoma Running Title: Modified RECIST (mrecist) for Hepatocellular Carcinoma Riccardo Lencioni Author s Affiliation: Division of Diagnostic
MRI of Benign Liver Lesions and Metastatic Disease Characterization with. Gadoxetate Disodium
MRI of Benign Liver Lesions and Metastatic Disease Characterization with Gadoxetate Disodium Rocky C. Saenz, D.O. Department of Diagnostic Radiology, Botsford Hospital, Farmington Hills, MI Introduction
and Malignant Compression Fractures of the Spine : Value of Adding Axial Diffusion-weighted MR Imaging at 3.0 T
and Malignant Compression Fractures of the Spine : Value of Adding Axial Diffusion-weighted MR Imaging at 3.0 T < SP47, Scientific abstract > Jinkyeong Sung, MD1, Won-Hee Jee, MD1, Joon-Yong Jung, MD1,
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
PET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
When is MRI Useful in Evaluating Renal Masses?
When is MRI Useful in Evaluating Renal Masses? Stuart G. Silverman, M.D., FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s s Hospital
Current Diagnostic Tools for Pancreatic Cancer
Current Diagnostic Tools for Pancreatic Cancer Presented by Pancreatic Cancer Action Network www.pancan.org November 14, 2013 If you experience technical difficulty during the presentation: Contact WebEx
Tumor vs. Necrosis. Leena M. Ketonen, MD, Ph.D. MD Anderson Cancer Center
Tumor vs. Necrosis Leena M. Ketonen, MD, Ph.D. MD Anderson Cancer Center May 2005 Presentation material is for education purposes only. All rights reserved. 2005 URMC Radiology Page 1 of 43 Presentation
Fat-containing lesions of the liver: What do we need to know about them?
Fat-containing lesions of the liver: What do we need to know about them? C. Santos Montón, S. del Carmen Martínez, M. Martin Izquierdo, D. C. Cuellar, A. Herrero Hernandez, J. F. Ojeda Esparza; Salamanca/ES
Adrenal Incidentalomas in the real world
Adrenal Incidentalomas in the real world Objectives 1. Define adrenal incidentaloma 2. Review the differential diagnosis of incidental adrenal lesions and the most common lesions 3. Provide a practical
LIVER TUMORS PROFF. S.FLORET
LIVER TUMORS PROFF. S.FLORET NEOPLASM OF LIVER PRIMARY 1)BENIGN 2)MALIGNANT METASTATIC/SECONDARY LIVER Primary Liver Cancer the Second Killer among tumors high morbidity and mortality(20.40/100,000) etiology
GE Healthcare. explore Locus Ultra. pre-clinical CT dynamic computed tomography
GE Healthcare explore Locus Ultra pre-clinical CT dynamic computed tomography High-performance, dynamic, volume CT With acquisition speeds as fast as one second, the explore Locus Ultra CT scanner from
PET/CT Imaging in Lung Cancer
PET/CT Imaging in Lung Cancer Mylene T. Truong, MD Mylene T. Truong M.D. Objectives To discuss the role of PET/CT in the staging of lung cancer To review the recommendations from American Society of Clinical
Whole Body MRI in Oncology: Neuroblastoma and Lymphoma. Whole Body MRI in Oncology. WB-MRI Techniques. Without a Moving Tabletop
Whole Body MRI in Oncology: Neuroblastoma and Lymphoma Marilyn J. Siegel, M.D. Mallinckrodt Institute of Radiology Washington University Medical Center St. Louis, MO Whole Body MRI in Oncology Describe
Multi-slice Helical CT Scanning of the Chest
Multi-slice Helical CT Scanning of the Chest Comparison of different low-dose acquisitions Lung cancer is the main cause of deaths due to cancer in human males and the incidence is constantly increasing.
UTILIZATION OF FOUR DIMENSIONAL ULTRASOUND IN THE DETECTION OF LIVER MASS
UTILIZATION OF FOUR DIMENSIONAL ULTRASOUND IN THE DETECTION OF LIVER MASS Ismael A Lapus, Diana A Payawal, Rodney L Fernan, RR Reyes Section of Gastroenterology, Cardinal Santos Medical Center San Juan,
Incidental Focal Liver Lesions FLLs and Incidentalomas. Disclosure. The speaker regrets he has no conflicts to declare. YET.. Objectives 11/9/2015
Incidental Focal Liver Lesions FLLs and Incidentalomas Gopal A. Ramaraju, MD Associate Professor Gastroenterology and Hepatology University of Rochester Medical School/ Strong Memorial Hospital Disclosure
Dr Wong Jen-San Raffles Hospital. Courtesy of Prof Pierce Chow
Dr Wong Jen-San Raffles Hospital Courtesy of Prof Pierce Chow 1 RHV 51 year old Child-Pugh A Hepatitis B + Platelet 278 CT: 6 cm HCC with extension of HCC into RPV and likely RHV RPV 2006 2 a. Surgical
Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma
Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma F. Edward Boas, MD, PhD; Bao Do, MD; John D. Louie, MD; Nishita Kothary, MD; Gloria L. Hwang, MD; William
L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
Sodium Fluoride PET/CT Bone Imaging: Theory and Practice
Sodium Fluoride PET/CT Bone Imaging: Theory and Practice George Segall, M.D. Stanford University Why F-18 Fluoride? Faster Higher Resolution Anatomic Correlation Chemiadsorption Hydroxyapatite Ca10(PO4)6(OH)2
Diagnostic Interventions of Small < 2.5mm Focal Liver Lesions: US and CT-guided Biopsy
World Journal of Research and Review (WJRR) ISSN:2455-3956, Volume-3, Issue-3, September 2016 Pages 68-71 Diagnostic Interventions of Small < 2.5mm Focal Liver Lesions: US and CT-guided Biopsy Atanas Dimitrov
Innovative RT SBRT. The variables with REQ in superscript are required.
The variables with REQ in superscript are required. The variables with a are single-select variables; only one answer can be selected. The variables with a are multi-select variables; multiple answers
PADUA score guided surgery for T1 RCC
PADUA score guided surgery for T1 RCC - Renal Cell Carcinoma - Vassilis Poulakis MD, PhD, FEBU Ass. Professor of Urology, University of Frankfurt, Germany Director of Urologic Clinic Metropolitan Hospital
DO NOT COPY. Indeterminate Focal Liver Lesions Incidentally Discovered at Gray-Scale US. Role of Contrast-Enhanced Sonography
ORIGINAL ARTICLE Indeterminate Focal Liver Lesions Incidentally Discovered at Gray-Scale US Role of Contrast-Enhanced Sonography Tommaso Vincenzo Bartolotta, MD, PhD,* Adele Taibbi, MD,* Massimo Midiri,
Spectroscopy & Imaging in Tissues with Diffuse Light
Spectroscopy & Imaging in Tissues with Diffuse Light Arjun G. Yodh Outline Optics and Physiological Background Introduction to Diffuse Light Some Applications Brain Breast In-Vivo Optical Biopsy (The Dream)
Department of Medical Imaging, Toronto General Hospital, University of Toronto, Toronto, ON, Canada
Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review Tae Kyoung Kim, Korosh Khalili, Hyun-Jung Jang epartment of Medical Imaging, Toronto General
Imaging of Soft Tissue Tumors
Imaging of Soft Tissue Tumors Leanne L Seeger, MD, FACR Professor & Chief, Musculoskeletal Imaging David Geffen School of Medicine at UCLA Department of Radiology Objectives 1. Apply understanding and
INCIDENTALOMAS The definition. Tumor (-oma)/lesion found by coincidence (incidental) without clinical symptoms or suspicion.
INCIDENTALOMAS The definition Tumor (-oma)/lesion found by coincidence (incidental) without clinical symptoms or suspicion. Worry gives a small thing a big shadow OBJECTIVES OF THIS TALK To appreciate
High Resolution Chest CT (HRCT): Protocol, Indications, and Pathologies
High Resolution Chest CT (HRCT): Protocol, Indications, and Pathologies David Levi, MD Atlantic Medical Imaging What is HRCT ACR defines HRCT as the use of thin section CT images (0.625 mm - 2 mm slice
Liver Cancer And Tumours
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
Imaging of Acute Stroke. Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group
Imaging of Acute Stroke Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group Modalities Non Contrast CT (NCCT) Contrast CT Angiography MRI MR Angiography Perfusion
Vascular ultrasound in aortic endoleaks
Vascular ultrasound in aortic endoleaks Nicos Labropoulos Professor of Surgery and Radiology Director, Vascular Laboratory Division of Vascular Surgery Stony Brook University Medical Center Stony Brook,
Dorith Shaham, M.D. Department of Radiology Hadassah Hebrew Uviversity Medical Center
Dorith Shaham, M.D. Department of Radiology Hadassah Hebrew Uviversity Medical Center LUNG CANCER The most common fatal malignancy in the Western world Estimated 1.3 million deaths worldwide in 2000 In
Translocation Renal Cell Carcinomas
Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)
Low Dose Helical CT for Lung Cancer Screening
Low Dose Helical CT for Lung Cancer Screening No Conflicts. No Disclosures. David K. Shelton UCDMC Lung Cancer Stages and Survival 213,000 new cases per yr #1 cause of cancer death 164,000 deaths/yr 5
MUSCULOSKELETAL ULTRASOUND EVALUATION OF THE PLANTAR PLATE FOR IDENTIFICATION OF PLANTAR PLATE TEARS
MUSCULOSKELETAL ULTRASOUND EVALUATION OF THE PLANTAR PLATE FOR IDENTIFICATION OF PLANTAR PLATE TEARS Erin E. Klein, DPM, MS Lowell Weil, Jr., DPM, MBA Lowell Scott Weil, Sr., DPM Jessica Knight, DPM Weil
Pancreatic Masses: What about Neuroendocrine Tumors? Daphne Ponce, HMS III Dr. Gillian Lieberman
Pancreatic Masses: What about Neuroendocrine Tumors? Daphne Ponce, HMS III Dr. Gillian Lieberman Agenda Epidemiology of Pancreatic Cancer Review Anatomy Case Presentation Differential Diagnosis Menu of